Aprea Therapeutics Inc (NQ: APRE )
3.510
-0.240
(-6.40%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Aprea Therapeutics Inc
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
From Aprea Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
From Aprea Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/84e47459-b235-4270-a600-7d65179a7872/small/unknown-png.png)
![](https://ml.globenewswire.com/media/84e47459-b235-4270-a600-7d65179a7872/small/unknown-png.png)
Aprea Therapeutics to Present at DDR Inhibitors Summit 2024
January 30, 2024
From Aprea Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
From Aprea Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
From Aprea Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.